Rchr
J-GLOBAL ID:201401032364993916   Update date: Sep. 17, 2023

INOUE HIROAKI

イノウエ ヒロアキ | INOUE HIROAKI
Affiliation and department:
Research field  (1): Hematology and oncology
Research keywords  (2): HIV感染症 ,  悪性リンパ腫
Papers (14):
  • Takahiro Haeno, Shinya Rai, Yoshiaki Miyake, Maiko Inoue, Ko Fujimoto, Aki Fujii, Yoshio Iwata, Shuji Minamoto, Takahide Taniguchi, Hiroaki Kakutani, et al. Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma. Journal of clinical and experimental hematopathology : JCEH. 2023. 63. 2. 99-107
  • Kentaro Serizawa, Hirokazu Tanaka, Takeshi Ueda, Ayano Fukui, Hiroaki Kakutani, Takahide Taniguchi, Hiroaki Inoue, Takahiro Kumode, Yasuhiro Taniguchi, Shinya Rai, et al. CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence. International Journal of Hematology. 2022. 115. 3. 336-349
  • Shinya Rai, Hiroaki Inoue, Kazuko Sakai, Hitoshi Hanamoto, Mitsuhiro Matsuda, Yasuhiro Maeda, Takahiro Haeno, Yosaku Watatani, Takahiro Kumode, Kentaro Serizawa, et al. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma. Cancer science. 2022. 113. 2. 660-673
  • Shinya Rai, Hiroaki Inoue, Hitoshi Hanamoto, Mitsuhiro Matsuda, Yasuhiro Maeda, Yusuke Wada, Takahiro Haeno, Yosaku Watatani, Takahiro Kumode, Chikara Hirase, et al. Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trial. International journal of hematology. 2021. 114. 2. 205-216
  • Hiroaki Inoue, Shinya Rai, Hirokazu Tanaka, J. Luis Espinoza, Maiko Komori-Inoue, Hiroaki Kakutani, Shuji Minamoto, Takahiro Kumode, Shoko Nakayama, Yasuhiro Taniguchi, et al. Epstein-Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy. Viruses. 2020. 12. 4. 416-416
more...
MISC (3):
Lectures and oral presentations  (24):
  • Interleukin-17産生のEvans症候群合併のangioimmunoblastic T-cell lymphomaの一例
    (日本リンパ網内系学会会誌 2019)
  • 治療抵抗性TAFRO症候群に合併したAILTの1例
    (日本リンパ網内系学会会誌 2019)
  • ヘモグロビン値と血小板数に基づくびまん性大細胞型B細胞リンパ腫、非特異型の新たな予後指標の提唱
    (日本リンパ網内系学会会誌 2019)
  • 十二指腸原発濾胞性リンパ腫における抗腫瘍免疫の寄与
    (日本リンパ網内系学会会誌 2019)
  • 単一施設における初回同種造血幹細胞移植376例の経年的影響
    (日本輸血細胞治療学会誌 2019)
more...
Education (1):
  • - 2008 Kindai University Faculty of Medicine
Professional career (1):
  • Doctor of Philosophy (medicine) (Kindai University Graduate School of Medical Sciences)
Work history (1):
  • - 現在 Kindai University Faculty of Medicine
Association Membership(s) (5):
日本リンパ網内系学会 ,  THE JAPANESE SOCIETY FOR AIDS RESEARCH ,  日本造血細胞移植学会 ,  THE JAPANESE SOCIETY OF HEMATOLOGY ,  THE JAPANESE SOCIETY OF INTERNAL MEDICINE
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page